4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-017556
SVP, Controller and PAO sold 732 shares at $138.17 ($101,140)
- SVP, Controller and PAO acquired 1,560 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Huizenga Theodore Alan · SVP, Controller and PAO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-01 | Grant or award : show line 1 in the form | +1,560 | 17,276 | D | ||
| 2021-03-01 | Sale : show line 2 in the form | −732 | $138.17 | $101,140 | 16,544 | D |
| Open-market sales · 732 sh · avg $138.17 · $101,140 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-01 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +4,655 | 4,655 | D |
Loading xslF345X03/doc4.xml…